In the current WHO 2021 classification, IDH1/2-mutant gliomas are further classified into those with a 1p/19q codeletion (oligodendrogliomas grade 2–3) and those without (astrocytomas grade 2–4). Here, IDH1 is linked to central nervous system cancer.